Monographs / Cardiovascular Risk and Testosterone Supplementation
expert
Physician-Scientist; Medical Director, Healthy Male; Director of Andrology Services, Hudson Institute of Medical Research; Consultant Andrologist, Monash IVF Group
This article examines the evidence for the cardiovascular safety of testosterone replacement therapy in older men with non-specific symptoms and unexplained low testosterone levels.
Written by Prof Robert I McLachlan, FRACP, PhD, AM
Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research is the Director of Andrology Australia and Deputy Director of Endocrinology at Monash Medical Centre. Rob specialises in the area of male reproductive medicine and has made significant contributions to research in endocrinology, infertility and andrology.
TIAs and Carotid Stenosis
Low libido - What is it & How is it Managed?
Functional Gastrointestinal Disorders in Infants – Practical Advice for HCPs
Using the New RSV Vaccine in Practice
expert
Physician-Scientist; Medical Director, Healthy Male; Director of Andrology Services, Hudson Institute of Medical Research; Consultant Andrologist, Monash IVF Group
Strongly support
Somewhat support
Neither support nor oppose
Somewhat oppose
Strongly oppose
Listen to expert interviews.
Click to open in a new tab
Browse the latest monographs from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.